Literature DB >> 8996629

Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts.

C I Pantos1, C H Davos, H C Carageorgiou, D V Varonos, D V Cokkinos.   

Abstract

Although ischaemic preconditioning (PC) has been shown to protect normal hearts from a subsequent ischaemic insult, its protective effect on the hypertrophied myocardium has not been widely studied. This study was designed to investigate whether ischaemic preconditioning protects hearts with hypertrophy (HYP). Cardiac HYP was produced in rats by suprarenal abdominal aortic constriction of 5 weeks' duration, and was defined as left ventricular weight: body weight [LVW: BW (mg/g)] ratio over 3.0. Isolated rat hearts were perfused with a modified Krebs-Henseleit buffer at 37 degrees C in a Langendorff preparation. Hearts from sham-operated animals (NORM) and those with HYP underwent a PC protocol consisting of 3 min of global zero flow ischaemia, 5 min of reperfusion followed by 5 min of ischaemia and 5 min of reperfusion. This was followed by 20 min ischaemia and 45 min reperfusion. Control hearts in the HYP and NORM groups were not subjected to the PC protocol. There were, thus, four experimental groups: NORM control (n = 9), NORM, PC (n = 9), HYP control (n = 9), HYP, PC (n = 11). The recovery of function after ischaemia was evaluated by recovery of left ventricular developed pressure (LVDP) expressed as % of the initial value (LVDP%). The LVW: BW ratio for the HYP groups was 3.4 (SEM 0.08). LVDP% was higher (p < 0.01) in preconditioned groups as compared with controls. In NORM control recovery was 49.3 (6.1), NORM, PC 76.5 (3.4), HYP control 39.8 (4.6) HYP, PC 70.1 (4.1). These data indicate that the ability of preconditioning to protect against ischaemic ventricular dysfunction is preserved in this model of cardiac hypertrophy.

Entities:  

Mesh:

Year:  1996        PMID: 8996629     DOI: 10.1007/bf00788725

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  20 in total

1.  Regression of myocardial hypertrophy. I. Experimental model, changes in heart weight, nucleic acids and collagen.

Authors:  A F Cutilletta; R T Dowell; M Rudnik; R A Arcilla; R Zak
Journal:  J Mol Cell Cardiol       Date:  1975-10       Impact factor: 5.000

2.  Preconditioning protects ischemic rabbit heart by protein kinase C activation.

Authors:  K Ytrehus; Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1994-03

3.  Phosphatidylinositol metabolism in hypertrophic rat heart.

Authors:  H Kawaguchi; H Sano; K Iizuka; H Okada; T Kudo; K Kageyama; S Muramoto; T Murakami; H Okamoto; N Mochizuki
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

4.  Increased injury of hypertrophied myocardium with ischemic arrest: preservation with hypothermia and cardioplegia.

Authors:  P Menasche; C Grousset; C S Apstein; F Marotte; C Mouas; A Piwnica
Journal:  Am Heart J       Date:  1985-12       Impact factor: 4.749

5.  Functional, morphological and metabolic characteristics of isolated hearts from normotensive and spontaneously hypertensive rats before, during and after renal hypertension.

Authors:  P Friberg; C Nordborg
Journal:  Acta Physiol Scand       Date:  1986-02

6.  Structural adaptation of the rat left ventricle in response to changes in pressure and volume loads.

Authors:  P Friberg; B Folkow; M Nordlander
Journal:  Acta Physiol Scand       Date:  1985-09

7.  Anoxia-induced changes in ventricular diastolic compliance in two models of hypertension in rats.

Authors:  F Callens-el Amrani; L Snoeckx; B Swynghedauw
Journal:  J Hypertens       Date:  1992-03       Impact factor: 4.844

8.  Ischaemic preconditioning protects hypertrophied myocardium.

Authors:  M E Speechly-Dick; G F Baxter; D M Yellon
Journal:  Cardiovasc Res       Date:  1994-07       Impact factor: 10.787

9.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10

10.  Myocardial protection with preconditioning.

Authors:  G C Li; J A Vasquez; K P Gallagher; B R Lucchesi
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

View more
  5 in total

Review 1.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

2.  Loss of cardioprotection induced by ischemic preconditioning after an initial ischemic period in isolated rat hearts.

Authors:  Alexandros D Cokkinos; Stylianos Tzeis; Panagiotis Moraitis; Constantinos Pantos; Hariklia Carageorgiou; Dimitrios Panousopoulos; Dennis D Varonos; Dennis V Cokkinos
Journal:  Exp Clin Cardiol       Date:  2003

Review 3.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

4.  Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction.

Authors:  Héctor F del Valle; Elena C Lascano; Jorge A Negroni; Alberto J Crottogini
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

Review 5.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.